Clinical Advances in Thyroid Cancer: Biomarker-Driven Diagnosis, Oncogenesis Insights, and Translational Therapies
A special issue of Current Oncology (ISSN 1718-7729). This special issue belongs to the section "Head and Neck Oncology".
Deadline for manuscript submissions: 31 December 2025 | Viewed by 481
Special Issue Editor
2. Center for Health Disparities & Molecular Medicine, Loma Linda University, Loma Linda, CA, USA
Interests: thyroid cancer; molecular biomarkers; enigma oncoprotein; fine needle aspiration
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Thyroid cancer is one of the most common endocrine malignancies, and its diagnosis and management have seen significant advancements in recent years. However, distinguishing between benign and malignant thyroid nodules remains a clinical challenge, particularly in fine-needle aspiration (FNA) samples. The identification of highly sensitive and specific molecular biomarkers, such as the novel oncoprotein Enigma, has the potential to revolutionize the precision of thyroid cancer diagnosis. Additionally, understanding the molecular mechanisms driving thyroid cancer oncogenesis is critical for developing targeted therapies and improving patient outcomes.
This Special Issue aims to highlight the latest research in molecular biomarker discovery, oncogenic pathways, and the translation of these findings into clinical practice.
We welcome original research articles and reviews that explore innovative diagnostic techniques, such as one-step real-time PCR, the role of novel oncoproteins, and the development of targeted therapeutic strategies. Contributions may also address the integration of molecular pathology with clinical decision making, paving the way for precision medicine in thyroid cancer care.
We look forward to receiving your contributions.
Dr. Salma Khan
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Current Oncology is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2200 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- thyroid cancer
- oncogenesis
- translational therapies
- fine-needle aspiration (FNA)
- precision medicine
- targeted therapy
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
